<DOC>
	<DOCNO>NCT01103037</DOCNO>
	<brief_summary>This study ass safety efficacy QAV680 patient mild moderate asthma</brief_summary>
	<brief_title>Efficacy , Safety Pharmacokinetics QAV680 Versus Placebo Patients With Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Patients moderate persistent asthma Smokers Any significant disease illness , asthma Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Mild</keyword>
	<keyword>Moderate</keyword>
	<keyword>Asthma</keyword>
</DOC>